US re-use industry set to lose half of product base
This article was originally published in Clinica
Executive Summary
Only 52% of the reprocessed single use devices now being marketed to hospitals will be allowed to stay on the market after studies suggest that many products do not stand up to reprocessing, the US FDA has announced.